BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22339352)

  • 1. Factors influencing epigenetic mechanisms and related diseases.
    Karagiannis TC; Maulik N
    Antioxid Redox Signal; 2012 Jul; 17(2):192-4. PubMed ID: 22339352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapies.
    Fratta E; Montico B; Rizzo A; Colizzi F; Sigalotti L; Dolcetti R
    Oncotarget; 2016 Aug; 7(35):57327-57350. PubMed ID: 27329599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic mechanisms in Alzheimer's disease: implications for pathogenesis and therapy.
    Wang J; Yu JT; Tan MS; Jiang T; Tan L
    Ageing Res Rev; 2013 Sep; 12(4):1024-41. PubMed ID: 23688931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic drugs in Alzheimer's disease.
    Cuadrado-Tejedor M; Oyarzabal J; Lucas MP; Franco R; García-Osta A
    Biomol Concepts; 2013 Oct; 4(5):433-45. PubMed ID: 25436752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenomic networking in drug development: from pathogenic mechanisms to pharmacogenomics.
    Cacabelos R
    Drug Dev Res; 2014 Sep; 75(6):348-65. PubMed ID: 25195579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epigenetic mechanisms of Alzheimer's disease and related drug research].
    Gong HC; Wang YL; Wang HW
    Yao Xue Xue Bao; 2013 Jul; 48(7):1005-13. PubMed ID: 24133967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's Disease and Histone Code Alterations.
    Narayan P; Dragunow M
    Adv Exp Med Biol; 2017; 978():321-336. PubMed ID: 28523554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epigenetic alterations in myelodysplastic syndromes].
    Xu F; Li X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):531-5. PubMed ID: 20416204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic treatment of neurological disease.
    Gray SG
    Epigenomics; 2011 Aug; 3(4):431-50. PubMed ID: 22126204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetically regulated microRNAs in Alzheimer's disease.
    Van den Hove DL; Kompotis K; Lardenoije R; Kenis G; Mill J; Steinbusch HW; Lesch KP; Fitzsimons CP; De Strooper B; Rutten BP
    Neurobiol Aging; 2014 Apr; 35(4):731-45. PubMed ID: 24238656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Basis of Lead-Induced Neurological Disorders.
    Wang T; Zhang J; Xu Y
    Int J Environ Res Public Health; 2020 Jul; 17(13):. PubMed ID: 32645824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early environmental factors, alteration of epigenetic marks and metabolic disease susceptibility.
    Portha B; Fournier A; Kioon MD; Mezger V; Movassat J
    Biochimie; 2014 Feb; 97():1-15. PubMed ID: 24139903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation in neurodegenerative disorders: a missing link between genome and environment?
    Iraola-Guzmán S; Estivill X; Rabionet R
    Clin Genet; 2011 Jul; 80(1):1-14. PubMed ID: 21542837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer chemoprevention and nutriepigenetics: state of the art and future challenges.
    Gerhauser C
    Top Curr Chem; 2013; 329():73-132. PubMed ID: 22955508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review.
    Vahid F; Zand H; Nosrat-Mirshekarlou E; Najafi R; Hekmatdoost A
    Gene; 2015 May; 562(1):8-15. PubMed ID: 25701602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epigenetic therapy in myelodysplastic syndromes].
    Maki K; Mitani K
    Rinsho Ketsueki; 2011 Jul; 52(7):438-46. PubMed ID: 21821974
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeting histone-modifications in Alzheimer's disease. What is the evidence that this is a promising therapeutic avenue?
    Fischer A
    Neuropharmacology; 2014 May; 80():95-102. PubMed ID: 24486385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation in the pathophysiology of Alzheimer's disease.
    Chouliaras L; Rutten BP; Kenis G; Peerbooms O; Visser PJ; Verhey F; van Os J; Steinbusch HW; van den Hove DL
    Prog Neurobiol; 2010 Apr; 90(4):498-510. PubMed ID: 20097254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone onco-modifications.
    Füllgrabe J; Kavanagh E; Joseph B
    Oncogene; 2011 Aug; 30(31):3391-403. PubMed ID: 21516126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress induces DNA demethylation and histone acetylation in SH-SY5Y cells: potential epigenetic mechanisms in gene transcription in Aβ production.
    Gu X; Sun J; Li S; Wu X; Li L
    Neurobiol Aging; 2013 Apr; 34(4):1069-79. PubMed ID: 23141413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.